These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10344036)

  • 1. Clinical profile of saruplase: mortality and safety.
    Betriu A
    Int J Clin Pract Suppl; 1998 Nov; 99():16-20. PubMed ID: 10344036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombolysis with saruplase versus streptokinase in acute myocardial infarction: five-year results of the PRIMI trial.
    Spiecker M; Windeler J; Vermeer F; Michels R; Seabra-Gomes R; vom Dahl J; Kerber S; Verheugt FW; Westerhof PW; Bär FW; Nixdorff U; Barth H; Hopkins GR; von Fisenne MJ; Meyer J
    Am Heart J; 1999 Sep; 138(3 Pt 1):518-24. PubMed ID: 10467203
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blind study comparing saruplase with streptokinase therapy in acute myocardial infarction: the COMPASS Equivalence Trial. Comparison Trial of Saruplase and Streptokinase (COMASS) Investigators.
    Tebbe U; Michels R; Adgey J; Boland J; Caspi A; Charbonnier B; Windeler J; Barth H; Groves R; Hopkins GR; Fennell W; Betriu A; Ruda M; Mlczoch J
    J Am Coll Cardiol; 1998 Mar; 31(3):487-93. PubMed ID: 9502624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical profile of saruplase: angiographic findings.
    Meyer J
    Int J Clin Pract Suppl; 1998 Nov; 99():9-15. PubMed ID: 10344035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pro-urokinase for infarct therapy].
    Spiecker M; Meyer J
    Herz; 1994 Dec; 19(6):326-35. PubMed ID: 7843689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Saruplase is a safe and effective thrombolytic agent; observations in 1,698 patients: results of the PASS study. Practical Applications of Saruplase Study.
    Vermeer F; Bösl I; Meyer J; Bär F; Charbonnier B; Windeler J; Barth H
    J Thromb Thrombolysis; 1999 Aug; 8(2):143-50. PubMed ID: 10436145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Saruplase versus other fibrinolytic agents.
    Michels HR
    Int J Clin Pract Suppl; 1998 Nov; 99():21-2. PubMed ID: 10344037
    [No Abstract]   [Full Text] [Related]  

  • 8. Newer thrombolytic drugs for acute myocardial infarction.
    Reddy DS
    Indian J Exp Biol; 1998 Jan; 36(1):1-15. PubMed ID: 9536645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of action and pharmacology of saruplase.
    Vermeer F
    Int J Clin Pract Suppl; 1998 Nov; 99():6-8. PubMed ID: 10344034
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of combined administration of saruplase and single-chain alteplase on coronary recanalization in acute myocardial infarction.
    Tranchesi B; Bellotti G; Chamone DF; Verstraete M
    Am J Cardiol; 1989 Jul; 64(3):229-32. PubMed ID: 2500842
    [No Abstract]   [Full Text] [Related]  

  • 11. New developments in thrombolytic therapy.
    Collen D; Gold HK
    Adv Exp Med Biol; 1990; 281():333-54. PubMed ID: 2129372
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combinations of thrombolytic agents in acute myocardial infarction.
    Bode C; Baumann H; von Hodenberg E; Freitag M; Nordt T
    Z Kardiol; 1993; 82 Suppl 2():125-8. PubMed ID: 8328189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombolytic therapy in a heart transplant recipient with acute myocardial infarction.
    Goldhammer EI; Kharash L; Abinader EG
    Isr Med Assoc J; 1999 Nov; 1(3):198-9. PubMed ID: 10731337
    [No Abstract]   [Full Text] [Related]  

  • 14. [Comparison of clinical efficacy of thrombolytic drugs in patients with acute myocardial infarction].
    López-Sendón JL
    Rev Esp Cardiol; 1992; 45 Suppl 2():9-20. PubMed ID: 1475514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic treatment in acute myocardial infarction.
    Verstraete M
    Circulation; 1990 Sep; 82(3 Suppl):II96-109. PubMed ID: 2118432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombolytic therapy of deep venous thrombosis. Indications, treatment procedures].
    Theiss W
    Internist (Berl); 1992 Apr; 33(4):225-31. PubMed ID: 1612846
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of saruplase, an unglycosylated single-chain urokinase-type plasminogen activator, in patients with acute myocardial infarction.
    Koster RW; Cohen AF; Hopkins GR; Beier H; Günzler WA; van der Wouw PA
    Thromb Haemost; 1994 Nov; 72(5):740-4. PubMed ID: 7534946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of changes in liver blood flow on the pharmacokinetics of saruplase in patients with acute myocardial infarction.
    van Griensven JM; Koster RW; Hopkins GR; Beier H; Günzler WA; Kroon R; Schoemaker RC; Cohen AF
    Thromb Haemost; 1997 Sep; 78(3):1015-20. PubMed ID: 9308746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombolytic treatment in acute myocardial infarction.
    Acar J; Vahanian A; Michel PL; Slama M; Cormier B; Roger V
    Semin Thromb Hemost; 1987 Apr; 13(2):186-200. PubMed ID: 2957791
    [No Abstract]   [Full Text] [Related]  

  • 20. [Thrombolytic (fibrinolytic) agents for treatment of ischemic heart disease].
    Nagao K; Kanmatsuse K
    Nihon Rinsho; 2003 Apr; 61 Suppl 4():641-6. PubMed ID: 12735044
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.